Access the full text.
Sign up today, get DeepDyve free for 14 days.
R. Hwang, A. González-Angulo, M. Yi, T. Buchholz, F. Meric-Bernstam, H. Kuerer, G. Babiera, W. Tereffe, Diane Liu, K. Hunt (2007)
Low locoregional failure rates in selected breast cancer patients with tumor‐positive sentinel lymph nodes who do not undergo completion axillary dissectionCancer, 110
Harry Bear, S. Anderson, A. Brown, Roy Smith, E. Mamounas, B. Fisher, R. Margolese, Heather Theoret, A. Soran, D. Wickerham, N. Wolmark (2003)
The effect on tumor response of adding sequential preoperative docetaxel to preoperative doxorubicin and cyclophosphamide: preliminary results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 21 22
K. Hunt, M. Yi, E. Mittendorf, C. Guerrero, G. Babiera, I. Bedrosian, R. Hwang, H. Kuerer, M. Ross, F. Meric-Bernstam (2009)
Sentinel Lymph Node Surgery After Neoadjuvant Chemotherapy is Accurate and Reduces the Need for Axillary Dissection in Breast Cancer PatientsAnnals of Surgery, 250
J. Boughey, J. Moriarty, A. Degnim, Melissa Gregg, Jason Egginton, K. Long (2010)
Cost Modeling of Preoperative Axillary Ultrasound and Fine-Needle Aspiration to Guide Surgery for Invasive Breast CancerAnnals of Surgical Oncology, 17
S. Mclaughlin, M. Wright, K. Morris, G. Giron, Michelle Sampson, J. Brockway, K. Hurley, E. Riedel, K. Zee (2008)
Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: objective measurements.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 26 32
A. Naik, J. Fey, M. Gemignani, A. Heerdt, L. Montgomery, J. Petrek, E. Port, V. Sacchini, L. Sclafani, K. VanZee, R. Wagman, P. Borgen, H. Cody (2004)
The Risk of Axillary Relapse After Sentinel Lymph Node Biopsy for Breast Cancer Is Comparable With That of Axillary Lymph Node Dissection: A Follow-up Study of 4008 ProceduresAnnals of Surgery, 240
B. Fisher, A. Brown, E. Mamounas, S. Wieand, A. Robidoux, R. Margolese, A. Cruz, Edwin Fisher, D. Wickerham, N. Wolmark, A. DeCillis, J. Hoehn, A. Lees, N. Dimitrov (1997)
Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 15 7
Robert Mansel, L. Fallowfield, M. Kissin, A. Goyal, Robert Newcombe, J. Dixon, C. Yiangou, K. Horgan, N. Bundred, I. Monypenny, D. England, M. Sibbering, Tholkifl Abdullah, L. Barr, U. Chetty, D. Sinnett, A. Fleissig, D. Clarke, P. Ell (2006)
Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial.Journal of the National Cancer Institute, 98 9
K. Fournier, A. Schiller, R. Perry, C. Laronga (2004)
Micrometastasis in the Sentinel Lymph Node of Breast Cancer Does Not Mandate Completion Axillary DissectionAnnals of Surgery, 239
P. Gimbergues, C. Abrial, X. Durando, G. Bouedec, F. Cachin, F. Penault-Llorca, M. Mouret-Reynier, F. Kwiatkowski, J. Maublant, A. Tchirkov, J. Dauplat (2008)
Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy Is Accurate in Breast Cancer Patients with a Clinically Negative Axillary Nodal Status at PresentationAnnals of Surgical Oncology, 15
H. Kim, B. Son, W. Lim, J. Seo, B. Koh, Jong Lee, G. Gong, S. Ahn (2010)
Impact of Omission of Axillary Lymph Node Dissection After Negative Sentinel Lymph Node Biopsy: 70-Month Follow-upAnnals of Surgical Oncology, 17
A. Giuliano, K. Hunt, K. Ballman, P. Beitsch, P. Whitworth, P. Blumencranz, A. Leitch, S. Saha, L. Mccall, M. Morrow (2011)
Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial.JAMA, 305 6
Y. Xing, M. Foy, D. Cox, H. Kuerer, K. Hunt, J. Cormier (2006)
Meta‐analysis of sentinel lymph node biopsy after preoperative chemotherapy in patients with breast cancerBritish Journal of Surgery, 93
K. Nason, B. Anderson, D. Byrd, L. Dunnwald, J. Eary, D. Mankoff, R. Livingston, R. Schmidt, K. Jewell, R. Yeung, R. Moe (2000)
Increased false negative sentinel node biopsy rates after preoperative chemotherapy for invasive breast carcinomaCancer, 89
A. Degnim, S. Zakaria, J. Boughey, N. Sookhan, C. Reynolds, J. Donohue, D. Farley, C. Grant, T. Hoskin (2010)
Axillary Recurrence in Breast Cancer Patients with Isolated Tumor Cells in the Sentinel Lymph Node [AJCC N0(i+)]Annals of Surgical Oncology, 17
JC Boughey, JH Donohue, JW Jakub (2010)
Number of lymph nodes identified at axillary dissection: effect of neoadjuvant chemotherapy and other factorsCancer, 116
Armando Giuliano, L. Mccall, P. Beitsch, Pat Whitworth, P. Blumencranz, A. Leitch, S. Saha, Kelly Hunt, M. Morrow, K. Ballman (2010)
Locoregional Recurrence After Sentinel Lymph Node Dissection With or Without Axillary Dissection in Patients With Sentinel Lymph Node Metastases: The American College of Surgeons Oncology Group Z0011 Randomized TrialAnnals of Surgery, 252
A. Giuliano, Ralph Jones, M. Brennan, R. Statman (1997)
Sentinel lymphadenectomy in breast cancer.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 15 6
J. Boughey (2009)
Neoadjuvant Chemotherapy in Invasive Breast Cancer Results in a Lower Axillary Lymph Node CountBreast Diseases: A Year Book Quarterly, 19
A. Giuliano, P. Dale, R. Turner, D. Morton, S. Evans, D. Krasne (1995)
Improved Axillary Staging of Breast Cancer with Sentinel LymphadenectomyAnnals of Surgery, 222
M. Baslaim, O. Malik, S. Al-Sobhi, E. Ibrahim, A. Ezzat, D. Ajarim, A. Tulbah, M. Chaudhary, R. Sorbris (2002)
Decreased axillary lymph node retrieval in patients after neoadjuvant chemotherapy.American journal of surgery, 184 4
C. Deurzen, B. Vriens, V. Tjan-Heijnen, E. Wall, M. Albregts, R. Hilligersberg, E. Monninkhof, P. Diest (2009)
Accuracy of sentinel node biopsy after neoadjuvant chemotherapy in breast cancer patients: a systematic review.European journal of cancer, 45 18
S. Hidar, M. Bibi, O. Gharbi, S. Tebra, A. Trabelsi, S. Korbi, N. Bouaouina, S. Ahmed, H. Khaïri (2009)
Sentinel lymph node biopsy after neoadjuvant chemotherapy in inflammatory breast cancer.International journal of surgery, 7 3
Theodore Kim, A. Giuliano, G. Lyman (2006)
Lymphatic mapping and sentinel lymph node biopsy in early‐stage breast carcinomaCancer, 106
I. Bedrosian, C. Reynolds, R. Mick, L. Callans, C. Grant, J. Donohue, D. Farley, Rose Heller, E. Conant, S. Orel, Thomas Lawton, D. Fraker, B. Czerniecki (2000)
Accuracy of sentinel lymph node biopsy in patients with large primary breast tumorsCancer, 88
A. Kelly, B. Dwamena, P. Cronin, R. Carlos (2009)
Breast cancer sentinel node identification and classification after neoadjuvant chemotherapy-systematic review and meta analysis.Academic radiology, 16 5
L. Wilke, L. Mccall, K. Posther, Pat Whitworth, D. Reintgen, A. Leitch, S. Gabram, A. Lucci, C. Cox, K. Hunt, J. Herndon, A. Giuliano (2006)
Surgical Complications Associated With Sentinel Lymph Node Biopsy: Results From a Prospective International Cooperative Group TrialAnnals of Surgical Oncology, 13
J. Boughey, J. Donohue, J. Jakub, C. Lohse, A. Degnim (2010)
Number of lymph nodes identified at axillary dissectionCancer, 116
A. Lucci, L. Mccall, P. Beitsch, Pat Whitworth, D. Reintgen, P. Blumencranz, A. Leitch, S. Saha, K. Hunt, A. Giuliano (2007)
Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 25 24
B. Fisher, C. Redmond, E. Fisher, M. Bauer, N. Wolmark, D. Wickerham, M. Deutsch, E. Montague, R. Margolese, R. Foster (1985)
Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation.The New England journal of medicine, 312 11
A. Buzdar, N. Ibrahim, D. Francis, D. Booser, E. Thomas, R. Theriault, L. Pusztai, Marjorie Green, B. Arun, S. Giordano, M. Cristofanilli, D. Frye, T. Smith, K. Hunt, S. Singletary, A. Sahin, M. Ewer, T. Buchholz, D. Berry, G. Hortobagyi (2005)
Significantly higher pathologic complete remission rate after neoadjuvant therapy with trastuzumab, paclitaxel, and epirubicin chemotherapy: results of a randomized trial in human epidermal growth factor receptor 2-positive operable breast cancer.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 23 16
I. Langer, W. Marti, U. Guller, H. Moch, F. Harder, D. Oertli, M. Zuber (2005)
Axillary Recurrence Rate in Breast Cancer Patients With Negative Sentinel Lymph Node (SLN) or SLN Micrometastases: Prospective Analysis of 150 Patients After SLN BiopsyAnnals of Surgery, 241
L. Newman, N. Pernick, V. Adsay, K. Carolin, P. Philip, Susan Sipierski, D. Bouwman, M. Kosir, Michael White, D. Visscher (2003)
Histopathologic Evidence of Tumor Regression in the Axillary Lymph Nodes of Patients Treated With Preoperative Chemotherapy Correlates With Breast Cancer OutcomeAnnals of Surgical Oncology, 10
Alexandra Brown, K. Hunt, Jeannie Shen, L. Huo, G. Babiera, M. Ross, F. Meric-Bernstam, B. Feig, H. Kuerer, J. Boughey, C. Ching, M. Gilcrease (2010)
Histologic changes associated with false‐negative sentinel lymph nodes after preoperative chemotherapy in patients with confirmed lymph node‐positive breast cancer before treatmentCancer, 116
J. Boughey, L. Middleton, L. Harker, B. Garrett, B. Fornage, K. Hunt, G. Babiera, P. Dempsey, I. Bedrosian (2007)
Utility of ultrasound and fine-needle aspiration biopsy of the axilla in the assessment of invasive lobular carcinoma of the breast.American journal of surgery, 194 4
Julie Bélanger, G. Soucy, L. Sidéris, G. Leblanc, P. Drolet, A. Mitchell, Y. Leclerc, J. Beaudet, M. Dufresne, P. Dubé (2008)
Neoadjuvant chemotherapy in invasive breast cancer results in a lower axillary lymph node count.Journal of the American College of Surgeons, 206 4
D. Krag, S. Anderson, T. Julian, A. Brown, S. Harlow, J. Costantino, T. Ashikaga, D. Weaver, E. Mamounas, L. Jalovec, T. Frazier, D. Noyes, A. Robidoux, H. Scarth, N. Wolmark (2010)
Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial.The Lancet. Oncology, 11 10
P. Rastogi, S. Anderson, H. Bear, C. Geyer, M. Kahlenberg, A. Robidoux, R. Margolese, J. Hoehn, V. Vogel, S. Dakhil, D. Tamkus, K. King, E. Pajon, Mary Wright, J. Robert, S. Paik, E. Mamounas, N. Wolmark (2008)
Preoperative chemotherapy: updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 26 5
T Kim, AE Giuliano, GH Lyman (2006)
Lymphatic mapping and sentinel lymph node biopsy in early-stage breast carcinoma: a metaanalysisCancer, 106
M. Sakakibara, T. Nagashima, M. Kadowaki, Y. Onai, Toshihiko Fujimori, Jissei Yokomizo, Hiroshi Suzuki, K. Fushimi, Y. Nakatani, M. Miyazaki (2009)
Clinical Significance of Axillary Microresiduals After Neoadjuvant Chemotherapy in Breast Cancer Patients with Cytologically Proven MetastasesAnnals of Surgical Oncology, 16
V. Stearns, C. Ewing, R. Slack, Marie Penannen, D. Hayes, T. Tsangaris (2002)
Sentinel lymphadenectomy after neoadjuvant chemotherapy for breast cancer may reliably represent the axilla except for inflammatory breast cancerAnnals of Surgical Oncology, 9
H. Kuerer, A. Sahin, K. Hunt, L. Newman, T. Breslin, F. Ames, M. Ross, A. Buzdar, G. Hortobagyi, S. Singletary (1999)
Incidence and impact of documented eradication of breast cancer axillary lymph node metastases before surgery in patients treated with neoadjuvant chemotherapy.Annals of surgery, 230 1
J. Beatty, Lisa Precht, K. Lowe, M. Atwood (2009)
Axillary-conserving surgery is facilitated by neoadjuvant chemotherapy of breast cancer.American journal of surgery, 197 5
H. Neuman, L. Carey, D. Ollila, C. Livasy, B. Calvo, A. Meyer, Hong-Jin Kim, M. Meyers, E. Dees, F. Collichio, Carolyn Sartor, D. Moore, L. Sawyer, Jill Frank, N. Klauber-DeMore (2006)
Axillary lymph node count is lower after neoadjuvant chemotherapy.American journal of surgery, 191 6
S. Álvarez, E. Añorbe, P. Alcorta, F. López, I. Alonso, J. Cortés (2006)
Role of sonography in the diagnosis of axillary lymph node metastases in breast cancer: a systematic review.AJR. American journal of roentgenology, 186 5
The timing of sentinel lymph node (SLN) biopsy in patients receiving neoadjuvant chemotherapy remains a debated topic, despite increasing literature supporting use of SLN biopsy after chemotherapy. This article outlines the arguments for SLN biopsy prior to initiation of systemic therapy versus after neoadjuvant chemotherapy and the literature surrounding this debate. Additionally, special patient populations, including patients with inflammatory breast cancer and those presenting with node-positive disease, are discussed. SLN biopsy after completion of chemotherapy is accurate for axillary staging of patients with clinically node-negative axillas at presentation, except for those with inflammatory breast cancer.
Current Breast Cancer Reports – Springer Journals
Published: Mar 9, 2011
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.